메뉴 건너뛰기




Volumn 40, Issue 9, 2008, Pages 3166-3169

Use of Everolimus in De Novo Renal Recipients: Initial Experience in the Greek Population

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BASILIXIMAB; CORTICOSTEROID; CREATININE; CYCLOSPORIN A; EVEROLIMUS; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

EID: 56049123703     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.09.038     Document Type: Article
Times cited : (2)

References (8)
  • 1
    • 16244378141 scopus 로고    scopus 로고
    • Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: a 3-year randomized, multicenter, phase III study
    • Lorber M.I., Mulgaonkar S., Butt K.M., et al. Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: a 3-year randomized, multicenter, phase III study. Transplantation 80 (2005) 244
    • (2005) Transplantation , vol.80 , pp. 244
    • Lorber, M.I.1    Mulgaonkar, S.2    Butt, K.M.3
  • 2
    • 0035884710 scopus 로고    scopus 로고
    • Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure
    • Johnson R.W., Kreis H., Oberbauer R., et al. Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure. Transplantation 72 (2001) 777
    • (2001) Transplantation , vol.72 , pp. 777
    • Johnson, R.W.1    Kreis, H.2    Oberbauer, R.3
  • 4
    • 11144357432 scopus 로고    scopus 로고
    • Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studies
    • Vitko S., Tedesco H., Eris J., et al. Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studies. Am J Transplant 4 (2004) 626
    • (2004) Am J Transplant , vol.4 , pp. 626
    • Vitko, S.1    Tedesco, H.2    Eris, J.3
  • 5
    • 0016916438 scopus 로고
    • Prediction of creatinine clearance from serum creatinine
    • Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31
    • (1976) Nephron , vol.16 , pp. 31
    • Cockcroft, D.W.1    Gault, M.H.2
  • 6
    • 33644696712 scopus 로고    scopus 로고
    • Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients
    • Vitko S., Margreiter R., Weimar W., et al. Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients. Am J Transplant 5 (2005) 2521
    • (2005) Am J Transplant , vol.5 , pp. 2521
    • Vitko, S.1    Margreiter, R.2    Weimar, W.3
  • 7
    • 3142718792 scopus 로고    scopus 로고
    • [Everolimus: immunosuppression with antilymphoproliferative therapy]
    • Pascual J. [Everolimus: immunosuppression with antilymphoproliferative therapy]. Nefrologia 24 (2004) 112
    • (2004) Nefrologia , vol.24 , pp. 112
    • Pascual, J.1
  • 8
    • 34147144078 scopus 로고    scopus 로고
    • Reversal of loss of glomerular filtration rate in children with transplant nephropathy after switch to everolimus and low-dose cyclosporine A
    • Pape L., Ahlenstiel T., Ehrich J.H.H., et al. Reversal of loss of glomerular filtration rate in children with transplant nephropathy after switch to everolimus and low-dose cyclosporine A. Pediatr Transplant 11 (2007) 291
    • (2007) Pediatr Transplant , vol.11 , pp. 291
    • Pape, L.1    Ahlenstiel, T.2    Ehrich, J.H.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.